Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 06 2024 - 6:30AM
Business Wire
Crescita Therapeutics Inc. (TSX: CTX and OTC US:
CRRTF) (“Crescita” or the “Company”), a growth-oriented,
innovation-driven Canadian commercial dermatology company, today
announced the voting results from its Annual General and Special
Meeting of Shareholders held at its corporate headquarters in
Laval, Quebec on June 5, 2024. The detailed results of the votes
received by proxy are as follows:
Election of Directors
Director Nominees
NUMBER OF SHARES
PERCENTAGE OF VOTES
CAST
FOR
WITHHELD
FOR
WITHHELD
Daniel N. Chicoine
6,490,732
109,026
98.3%
1.7%
Anthony E. Dobranowski
6,508,888
90,870
98.6%
1.4%
John C. London
6,533,190
66,568
99.0%
1.0%
Deborah Shannon-Trudeau
6,541,297
58,461
99.1%
0.9%
Serge Verreault
6,590,211
9,547
99.9%
0.1%
Reappointment of External Auditors
Outcome
NUMBER OF SHARES
PERCENTAGE OF VOTES
CAST
FOR
WITHHELD
FOR
WITHHELD
Ernst & Young LLP
reappointed
7,212,551
148,556
98.0%
2.0%
Approval of the Continuation of Crescita’s Share Incentive
Plan
Outcome
NUMBER OF SHARES
PERCENTAGE OF VOTES
CAST
FOR
AGAINST
FOR
AGAINST
Share Incentive Plan approved
6,526,477
73,281
98.9%
1.1%
About Crescita Therapeutics Inc.
Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented,
innovation-driven Canadian commercial dermatology company with
in-house R&D and manufacturing capabilities. The Company offers
a portfolio of high-quality, science-based non-prescription
skincare products and a commercial stage prescription product. We
also own multiple proprietary transdermal delivery platforms that
support the development of patented formulations to facilitate the
delivery of active ingredients into or through the skin. For more
information visit, www.crescitatherapeutics.com.
Source: Crescita Therapeutics
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240606355142/en/
Linda Kisa, CPA, CA Vice-President, Reporting and Corporate
Affairs Email: lkisa@crescitatx.com
Crescita Therapeutics (TSX:CTX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Crescita Therapeutics (TSX:CTX)
Historical Stock Chart
From Nov 2023 to Nov 2024